Dermapharm Holding Se · XETR:DMP
Dermapharm — Fact Sheet (June 2024)
2 slides from Dermapharm's fact sheet, Jun 30, 2024
Slide 1: Fact Sheet H1 2024
FA C T SHEET H 1 2024 C O M PA N Y P R O F I L E REASONS TO INVEST Dermapharm is an innovative and fast-growing manufactur- 01 Clear focus on “Made in Europe” er of branded pharmaceuticals and other healthcare prod- 0 2 High-growth pharmaceutical manufacturer ucts. Founded in 1991, the company is ba
Slide 2: The three segments of Dermapharm Holding SE
T H E T H R E E S E G M E N T S O F D E R M A P H A R M H O L D I N G S E ( I N T E G R AT E D B U S I N E S S M O D E L ) BRANDED PHARMACEUTICALS Branded pharmaceuticals With more than 390 active pharmaceutical ingredients, Dermapharm markets more than 1,300 marketing authorisations. The range of m
Dermapharm Holding — Fact Sheet (June 2024) on 6ix